Search results for "Soft Tissue Neoplasm"

showing 10 items of 52 documents

Presurgical Ultrasound-Guided Anchor-Wire Marking of Soft Tissue Metastases in Stage III Melanoma Patients

2001

Background. Due to increased sensitivity of diagnostic procedures, soft tissue metastases in melanoma patients are frequently detected very early. However, small sizes, deep location, or position close to vulnerable structures could render subsequent surgery quite difficult. Objective. To test the feasibility and effectiveness of presurgical ultrasound-guided anchor-wire marking of melanoma metastases. Methods. We selected melanoma patients with cytologically proven metastases in clinical stage III which were either unfavorably located or which have failed removal by previous surgery. Anchor-wire marking was performed ultrasound guided and free-hand style without the use of local anesthesia…

AdultMalemedicine.medical_specialtySkin NeoplasmsSoft Tissue NeoplasmsDermatologyPreoperative careMetastasisLesionPreoperative CareHumansMedicineLocal anesthesiaStage (cooking)MelanomaAgedUltrasonographybusiness.industryMelanomaSoft tissueGeneral MedicineMiddle Agedmedicine.diseaseUltrasound guidedSurgeryFeasibility StudiesFemaleSurgerymedicine.symptombusinessDermatologic Surgery
researchProduct

Ki-67 immunoexpression and radiological assessment of necrosis improves accuracy of conventional and modified core biopsy systems in predicting the f…

2021

Based on the French Federation Nationale des Centers de Lutte Contre le Cancer (FNCLCC) grading system, this study assesses the accuracy of conventional and modified core biopsy (CB) systems in predicting the final grade (low vs high) assigned to the resected specimen. Substituting Ki-67 immunoexpression for mitotic count, and radiological for histological assessment of necrosis, we used two modified FNCLCC CB grading systems: (1) Ki-67 immunoexpression alone, and (2) Ki-67 plus radiological assessment of necrosis. We graded 199 soft tissue sarcomas (STS) from nine centers, and compared the results for the conventional (obtained from local histopathology reports) and modified CB systems wit…

AdultMalemedicine.medical_specialtySoft Tissue NeoplasmsPathology and Forensic MedicineRadiological necrosisNecrosisCore biopsymedicineBiomarkers TumorHumansGrading (education)Retrospective StudiesNot evaluatedReceiver operating characteristicbiologybusiness.industrySarcomasSoft tissueSarcomaCell Biologymedicine.diseaseKi-67 AntigenRadiological weaponKi-67biology.proteinKi-67HistopathologyFemaleSarcomaBiopsy Large-Core NeedleNuclear medicinebusinessFNCLCC grading system
researchProduct

Phase II study of continuous-infusion high-dose ifosfamide in advanced and/or metastatic pretreated soft tissue sarcomas.

1998

Summary Background Ifosfamide has important activity in pretreated soft tissue sarcomas (STS), and recent data support a clinically significant dose-response relationship for this agent. Administration by continuous infusion and hematopoietic support have rendered dose intensification regimens possible by reducing both hematologic and non-hematologic toxicities. The optimal dose and schedule of ifosfamide when given at high doses remain to be defined. In a previous phase I study, we demonstrated the feasibility of a continuous infusion (c.i.) high-dose ifosfamide (HDI) regimen in the ambulatory setting for patients with advanced solid tumors. The objective of the present phase II study was …

AdultMalemedicine.medical_specialtymedicine.medical_treatmentUrologyPhases of clinical researchSoft Tissue NeoplasmsNeutropeniaDrug Administration Schedulechemistry.chemical_compoundGranulocyte Colony-Stimulating FactormedicineHumansIfosfamideInfusions IntravenousAntineoplastic Agents AlkylatingMesnaAgedMesnaChemotherapyIfosfamidebusiness.industrySarcomaHematologyMiddle Agedmedicine.diseaseChemotherapy regimenNitrogen mustardSurgeryRegimenTreatment OutcomeOncologychemistryFemalebusinessmedicine.drugAnnals of oncology : official journal of the European Society for Medical Oncology
researchProduct

Liposomal-encapsulated doxorubicin plus cyclophosphamide as first-line therapy in metastatic breast cancer: a phase II multicentric study

2007

Abstract Background The objective of this study is to evaluate the efficacy and toxicity of the liposome-encapsulated doxorubicin (TLC D-99) plus cyclophosphamide (CTX) as first-line treatment of metastatic breast cancer in light of the potential cardioprotective effect of TLC D-99 as compared with conventional doxorubicin. Materials and methods Sixty-seven patients as defined according Simon's two-stage phase II design were enrolled. They received TLC D-99 at the dosage of 60 mg/m2 plus CTX 600 mg/m2, with cycles repeated every 3 weeks. Cardiac function was assessed by ultrasonography at baseline and every two cycles. Results The principal characteristics of the 67 enrolled patients were a…

Adultmedicine.medical_specialtySkin NeoplasmsCyclophosphamideSettore MED/06 - Oncologia MedicaPhases of clinical researchBreast NeoplasmsSoft Tissue NeoplasmsAsymptomaticGastroenterologyDrug Delivery SystemsBreast cancerInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineMucositisHumansAntineoplastic Agents AlkylatingCyclophosphamideAgedAntibiotics AntineoplasticPerformance statusbusiness.industryHematologyMiddle Agedmedicine.diseasedoxorubicin cyclophosphamide breast cancerMetastatic breast cancerSurgeryOncologyDoxorubicinLiposomesToxicityCarcinoma Squamous CellFemalemedicine.symptombusinessmedicine.drug
researchProduct

EWS/FLI-1 rearrangement in small round cell sarcomas of bone and soft tissue detected by reverse transcriptase polymerase chain reaction amplificatio…

1994

Recent cloning of the t(11;22) region has led to the detection of a number of sequences involved in the breakpoints by substituting a sequence which encodes a putative RNA binding domain for that of the DNA binding domain of the human homologue of murine FLI-1. Several tumours display consistent translocation at t(11;22) (q24;q12), a finding that suggests these fusion transcripts could be expressed and detected by reverse transcriptase polymerase chain reaction amplification. To date, only a small number of Ewing's sarcomas (Es) and peripheral neuroectodermal tumours (pPNET) of bone have been tested with this novel molecular biology approach. In this study, we confirmed the presence of the …

Cancer ResearchPathologymedicine.medical_specialtyChromosomes Human Pair 22Molecular Sequence DataTransplantation HeterologousEctomesenchymomaMice NudeBone NeoplasmsSoft Tissue NeoplasmsSarcoma EwingBone SarcomaBiologyPolymerase Chain ReactionTranslocation GeneticMiceProto-Oncogene ProteinsmedicineAnimalsHumansNeuroectodermal tumorBase SequenceProto-Oncogene Protein c-fli-1Soft tissue sarcomaChromosomes Human Pair 11Ewing's sarcomaRNA-Directed DNA PolymeraseGene rearrangementmedicine.diseaseDNA-Binding ProteinsReal-time polymerase chain reactionOncologySarcoma Small CellCancer researchTrans-ActivatorsOsteosarcomaEuropean journal of cancer (Oxford, England : 1990)
researchProduct

Ultrasonography for evaluation of the carotid artery in head and neck cancer.

1994

The dynamic relationship of lymph node metastases to surrounding vascular structures in the neck is important for preoperative patient assessment. When carotid artery involvement is suspected, this relationship often determines whether or not to operate. In the case of adhesive neck metastases along the internal jugular vein, it becomes possible to predict preoperatively if the integrity of this vein may be preserved. Ultrasonography has the ability to differentiate subtle from gross adherence, or simple compression from vascular invasion. This is done by manually palpating the tumor mass and asking the patient to perform various maneuvers while observing on a monitor the relationship of th…

Carotid Artery Diseasesmedicine.medical_specialtyUltrasonography Doppler TranscranialSoft Tissue NeoplasmsPalpationPreoperative CaremedicineHumansNeoplasm InvasivenessVeinLymph nodeInternal jugular veinNeoplasm Stagingmedicine.diagnostic_testbusiness.industryHead and neck cancerUltrasoundMagnetic resonance imagingmedicine.diseaseMagnetic Resonance ImagingCerebral Angiographymedicine.anatomical_structureCarotid ArteriesOtorhinolaryngologyHead and Neck NeoplasmsLymphatic Metastasiscardiovascular systemNeck DissectionRadiologybusinessTomography X-Ray ComputedArteryThe Laryngoscope
researchProduct

Chromosomal and genetic changes produced in tumoral progression of embryonal rhabdomyosarcoma

2013

Disease free survivalHistologyFatal outcomeSoft Tissue Neoplasmbusiness.industryDisease progressionGeneral Medicinemedicine.diseasePathology and Forensic MedicineText miningCancer researchmedicineCombined Modality TherapyEmbryonal rhabdomyosarcomabusinessHistopathology
researchProduct

[Bilateral elastofibroma dorsi].

1999

Ein 75 jahriger Patient stellte sich mit seit 2 Jahren langsam grosenprogredienten Raumforderungen unterhalb beider Schulterblatter vor. Anamnestisch bestand ein Zustand nach proximaler Oberarmamputation linksseitig mit folgender prothetischer Versorgung. Klinisch zeigten sich direkt unter den Schulterblattspitzen beidseits 2 faustgrose Tumoren, die fest mit dem tiefer gelegenen Gewebe verwachsen waren. Sowohl magnetresonanztomographisch als auch intraoperativ stellte sich ein infiltratives Wachstum dieser Raumforderungen in die seitliche Thoraxmuskulatur und das Periost der Rippen sowie des Schulterblatts dar, so das ein maligner Tumor vermutet wurde. Histopathologisch zeigte sich Bindegew…

GynecologyMalemedicine.medical_specialtybusiness.industrySoft Tissue NeoplasmsFibromaThoracic NeoplasmsMagnetic Resonance ImagingScapulaTransplant surgeryConnective TissuemedicineHumansSurgeryFemaleNeoplasm InvasivenessbusinessAgedDer Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen
researchProduct

p16INK4A (CDKN2A) gene deletion is a frequent genetic event in synovial sarcomas.

2006

We assessed the frequency of genomic deletion of p16 INK4A (CDKN2A) in synovial sarcomas (SSs) and its possible association with immunoexpression of p16 and cyclin D1 and the Ki-67 proliferation index using dualcolor fluorescence in situ hybridization (FISH) on tissue microarray sections of 41 histologically and molecularly confirmed SSs. A heterozygous p16 INK4A gene deletion was identified in 28 (74%) of 38 cases, with 25 (89%) of them showing abnormal p16 protein expression (20 negative and 5 heterogeneous). Of 25 cases, 19 (76%) exhibiting increased cyclin D1 expression also demonstrated heterozygous p16 INK4A deletion. No significant association was observed between p16 INK4A deletion …

HeterozygoteProliferation indexTumor suppressor geneSoft Tissue NeoplasmsBiologySarcoma SynovialCyclin D1CDKN2ACyclin DCyclinsmedicineBiomarkers TumorHumansCDKN2A Gene DeletionCyclin-Dependent Kinase Inhibitor p16In Situ Hybridization FluorescenceCell Nucleusmedicine.diagnostic_testGeneral Medicinemedicine.diseaseImmunohistochemistrySynovial sarcomaKi-67 AntigenTumor progressionTissue Array AnalysisCancer researchGene DeletionFluorescence in situ hybridizationAmerican journal of clinical pathology
researchProduct

Effects of tumor necrosis factor-alpha on tumor blood flow and hyperthermic treatment.

1989

The impact of recombinant human tumor necrosis factor-alpha (rhTNF-alpha), given alone or in combination with local hyperthermia, on perfusion and growth of a moderately rhTNF-alpha-sensitive rat tumor (DS-carcinosarcoma) was investigated. DS-carcinosarcomas were implanted into the hind foot dorsum of Sprague-Dawley rats. Tumor blood flow (TBF) was measured with the krypton-85 clearance technique. Treatment with either tumor necrosis factor-alpha (0.1-1.0 mg/kg) or hyperthermia (43.3 and 44.3 degrees C, 40 min) can decrease the perfusion of malignant tumors. The TBF reduction was fully established 2 h after rhTNF-alpha injection and lasted for at least 4 h. The application of local hyperthe…

HyperthermiaCancer ResearchNecrosisSoft Tissue NeoplasmsPharmacologyCarcinosarcomaTumor perfusionmedicineAnimalsTumor growthTumor necrosis factor αbusiness.industryTumor Necrosis Factor-alphaRats Inbred StrainsHematologyBlood flowHyperthermia Inducedmedicine.diseaseCombined Modality TherapyRecombinant ProteinsRatsOncologyRegional Blood FlowImmunologyTumor necrosis factor alphamedicine.symptombusinessPerfusionCell DivisionNeoplasm TransplantationOnkologie
researchProduct